TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria
about
Stxbp4 regulates DeltaNp63 stability by suppression of RACK1-dependent degradationThe Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase ItchPKCδ stabilizes TAp63 to promote cell apoptosisRegulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinomaTumor suppressors: enhancers or suppressors of regeneration?Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63.Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signalingThe microRNA feedback regulation of p63 in cancer progressionDNA damage response genes and the development of cancer metastasisThe Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineageDifferential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null miceDysregulated ΔNp63α inhibits expression of Ink4a/arf, blocks senescence, and promotes malignant conversion of keratinocytesOTX2 regulates the expression of TAp63 leading to macular and cochlear neuroepithelium development.Role of p63 and the Notch pathway in cochlea development and sensorineural deafnessDifferences in the transactivation domains of p53 family members: a computational study.TAp63 suppress metastasis via miR-133b in colon cancer cells.Regulation of p63 protein stability via ubiquitin-proteasome pathway.p63 transcriptionally regulates the expression of matrix metallopeptidase 13.Gene bi-targeting by viral and human miRNAsNAD(P)H quinone oxidoreductase protects TAp63gamma from proteasomal degradation and regulates TAp63gamma-dependent growth arrest.Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy∆N-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites.Interactions of the p53 protein family in cellular stress response in gastrointestinal tumorsTAp63 is a transcriptional target of NF-kappaB.Targeting of p53-transcriptional dysfunction by conditionally replicating adenovirus is not limited by p53-homologues.TAp63 induces senescence and suppresses tumorigenesis in vivo.The role of mutant p53 in human cancer.Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure.Inhibition of pluripotent stem cell-derived teratoma formation by small moleculesMetabolic effect of TAp63α: enhanced glycolysis and pentose phosphate pathway, resulting in increased antioxidant defensep53 Family and Cellular Stress Responses in Cancer.ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damageDeltaNp63alpha confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulationFunctional p53 is required for rapid restoration of daunorubicin-induced lesions of the spleenPreclinical evaluation of 4-methylthiobutyl isothiocyanate on liver cancer and cancer stem cells with different p53 statusPoly (C)-binding protein 1 regulates p63 expression through mRNA stability.Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha).The E3 ubiquitin ligase Itch controls the protein stability of p63p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.Tumor protein p63/nuclear factor κB feedback loop in regulation of cell death.
P2860
Q24311751-513673F0-820D-47A4-A68F-DC7D18E7D577Q24314498-D4ADE637-FEFA-4571-B95E-0F7AA1E114CBQ24338266-3DCCA187-9306-4E8A-B204-3C55FACD3437Q24617555-2FDE9042-6A15-4F8A-A057-DC050791E5D5Q24618747-4851392D-371A-4F74-B416-C2E862539021Q25256716-64640F4E-A70A-41C1-B470-19256998ED07Q26992094-8359EECA-780E-4ABC-87BD-F48D5D2F6ED4Q28084646-8AC2A9A0-052D-4B4E-B841-3B023FFC677CQ28388312-CCD11CC0-AB78-4284-B01C-ACDECD546704Q28505604-7A5454C3-9223-470D-BB40-B4E7C1078492Q28589270-621BBC39-7105-4DD2-9373-03D6EB79A384Q28742570-10C22089-3469-40D2-B643-7AEE8E98815BQ30394275-97EC4D04-5CAF-4DCC-A626-E01319BDCCAEQ30454583-27A2542B-D484-4534-B9CC-4B35544F70EDQ33531524-42F33EF3-5A1F-486B-B9C8-19BECD6B1447Q33555190-4C2DDC5F-ADD6-46FB-95B9-11CE7A24B204Q33562444-D7C33B05-FBA7-4B0E-81AE-29AC7A1BD8D1Q33576855-3157D0F1-EE90-4E49-A7DD-8EA2D22ED6D5Q33577390-268DE987-4F2A-4828-9951-A5526F251F12Q33627637-53531C13-DFD1-43A8-9E3B-6FF531C4787CQ33633277-D29D0FD3-1544-4BAE-9948-DE607D603000Q33688548-BDC9DC25-EB68-4594-B8E8-C6D5A75904FFQ33725939-216AF691-03EB-4C4B-8C03-64085EA558F4Q33866001-CB722269-00D6-42FA-8F52-B2431CB86B49Q33931595-74F9FA75-0EDC-40B1-B2BA-E858C3E3F89DQ34060915-A48CC11E-D0D9-4EA9-B4EA-8E6E1B8AFC51Q34153014-62BAA946-C20A-4407-BE23-74C448D28B1BQ34231282-6626564F-54DB-47EB-A6A9-F3548E9A8FDCQ34362039-65DF9C7C-ADF9-4B89-B781-B9B3EB3AB85EQ34365852-69C2641D-8919-414E-A0BA-2C1339BBA04FQ34377287-64D6D972-2624-4B22-BB68-87C4FC963FDAQ34753639-3579C790-47FF-4989-909F-51D5AC0D0877Q34795259-D4DF531D-AB16-4F4E-BFBE-45E2067F41FDQ34810055-97986ADA-C5DB-4CA6-A0C1-66408BC42A59Q34926255-8EB768FD-6D9F-459D-8A27-975C431979DAQ34938075-F0EE4780-C634-4B0B-8DA2-243FB2D8E37DQ34963231-0117FCED-1E75-4AF3-81E0-1B29E8D5D289Q34999004-A3444C30-82B6-4A3D-AC67-999B7024D0EEQ35227440-48EF85AC-B0AF-49F3-B2AC-C51CEE1E45FAQ35604493-0D89DE64-4479-446B-848F-85976AD5D952
P2860
TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria
@en
type
label
TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria
@en
prefLabel
TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria
@en
P2093
P2860
P50
P356
P1433
P1476
TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria
@en
P2093
Andreas Koch
Anna Maria Lena
Eleonora Candi
Elisa Schulze Schleithoff
Gerry Melino
Henning Schulze-Bergkamen
Katja Lorenz
Maria Valeria Catani
Martina Müller
Olav Gressner
P2860
P304
P356
10.1038/SJ.EMBOJ.7600708
P407
P577
2005-06-09T00:00:00Z